Risk score = (0.0951 × Exp APOBEC3G) + (−0.1621 × Exp AUH) + (0.0945 × Exp DAZL) + (0.1571 × Exp EIF4A1) + (0.1190 × Exp IGF2BP3) + (0.0998 × Exp NR0B1) + (0.1722 × Exp RPL36A) + (0.2380 × Exp TRMT1) Based on the median risk score, 539 ccRCC patients in the TCGA cohort were divided into low-risk and high-risk subgroups for survival analysis to assess the predictive power of the model. This evidence concerns the gene TRMT1 and nonpapillary renal cell carcinoma.